| Title |
Zoledronic acid in the management of metastatic bone disease
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, February 2008
|
| DOI | 10.2147/tcrm.s2707 |
| Pubmed ID | |
| Authors |
Thomas J Polascik, Vladimir Mouraviev |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 20% |
| Australia | 1 | 20% |
| United States | 1 | 20% |
| United Kingdom | 1 | 20% |
| Unknown | 1 | 20% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 3 | 60% |
| Members of the public | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | 1% |
| Portugal | 1 | 1% |
| Unknown | 96 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 16% |
| Student > Ph. D. Student | 13 | 13% |
| Student > Master | 13 | 13% |
| Other | 8 | 8% |
| Student > Postgraduate | 8 | 8% |
| Other | 18 | 18% |
| Unknown | 22 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 38% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
| Agricultural and Biological Sciences | 7 | 7% |
| Chemistry | 5 | 5% |
| Biochemistry, Genetics and Molecular Biology | 5 | 5% |
| Other | 13 | 13% |
| Unknown | 22 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2021.
All research outputs
#6,580,621
of 25,402,889 outputs
Outputs from Therapeutics and Clinical Risk Management
#321
of 1,323 outputs
Outputs of similar age
#36,377
of 172,963 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#13
of 21 outputs
Altmetric has tracked 25,402,889 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 21 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.